Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
High-throughput screening primary assay to identify small molecule activators of human guanylyl cyclase B (GC-B) receptor activity
Assay data:399 Active, 370620 Tested
SummaryCompounds, Active
CMV-Luciferase Counterscreen for Inhibitors of ATXN expression
Assay data:671 Active, 1 Activity ≤ 1 nM, 138 Activity ≤ 1 µM, 2145 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Firefly Luciferase Counterscreen for Inhibitors of ATXN expression
Assay data:31 Active, 8 Activity ≤ 1 µM, 1407 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Depositor
High-throughput screening primary assay to identify small molecule activators of human GC-A enzyme activity
Assay data:519 Active, 370620 Tested
Primary qHTS assay for inhibitors of human arachidonate 12S-lipoxygenase (ALOX12): Round 2
Assay data:6069 Active, 5332 Activity ≤ 1 µM, 575118 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Displacement of 6N-FAM from SF1 LBD (218 to 461 residues) (unknown origin) expressed in Escherichia coli BL21 pLysS by competitive binding based fluorescence polarization assay
Assay data:5 Active, 2 Activity ≤ 1 µM, 8 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Displacement of 6N-FAM from human LRH1 LBD (299 to 541 residues) expressed in Escherichia coli BL21 pLysS by competitive binding based fluorescence polarization assay
Assay data:6 Active, 4 Activity ≤ 1 µM, 8 Tested
Antagonist identification of Pyk2 oligomerization: high-throughput screening cellular assay
Assay data:818 Active, 98760 Tested
qHTS Assay for Foot and Mouth Disease Virus Antivirals: Primary Screen against the MLPCN compound library
Assay data:1964 Active, 408697 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
qHTS for Suppressors of FUS Proteinopathy: Primary screen using FUS-linked yeast assay
Assay data:932 Active, 388864 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: Primary Screen
Assay data:257 Active, 407462 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Inhibitor identification of TROY dependent signaling using uHTS single point assay
Assay data:3555 Active, 360980 Tested
qHTS assay for inhibitors of human lactate dehydrogenase
Assay data:736 Active, 484712 Tested
SummaryCompounds, ActivePubMed Citation
qHTS for small molecular inhibitors of PI4K2A
Assay data:535 Active, 419349 Tested
SSB-PriA antibiotic resistant target AlphaScreen
Assay data:2577 Active, 432182 Tested
qHTS Assay for Antagonists of the Relaxin Receptor RXFP1
Assay data:2064 Active, 352386 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
uHTS identification of small molecule modulators of Rev-erb Alpha.
Assay data:2957 Active, 372399 Tested
uHTS identification of small molecule modulators of NR3A
Assay data:8485 Active, 340002 Tested
A screen for compounds that are lethal to S. aureus RN4220
Assay data:1071 Active, 329176 Tested
A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted
Assay data:1792 Active, 329176 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on